| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Dunlop A. Sinclair is a Director at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $6.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $65.33 | $32,665.00 | -0.4% | +35.8% | -3.2% | |
| Feb 1, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $52.61 | $26,305.00 | -0.4% | +51.1% | +12.9% | |
| Jan 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $50.70 | $25,350.00 | -0.4% | +52.5% | +19.3% | |
| Dec 1, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $49.93 | $24,965.00 | -0.4% | +28.5% | +23.7% | |
| Nov 1, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 500 | $60.83 | $30,415.00 | -0.4% | -13.1% | -17.7% | |
| Sep 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 15,000 | $65.00 | $975,000.00 | -5.9% | -30.7% | -39.3% | |
| Aug 11, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 30,000 | $65.63 | $1,968,900.00 | -10.5% | -32.8% | -50.5% | |
| Jun 27, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 1,341 | $46.79 | $62,742.84 | -50.0% | +27.8% | +86.3% | |
| Jun 23, 2022 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 15,000 | $45.00 | $675,000.00 | -5.0% | +33.8% | +81.5% | |
| May 20, 2021 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 162,873 | $52.54 | $8,558,128.64 | -9.4% | +20.6% | -8.5% |